AGM
SLDB icon

Alpine Global Management’s Solid Biosciences SLDB Stock Holding History

Alpine Global Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,918
Closed -$124K – 431
2024
Q2 		$124K Buy
+21,918
New +$196K 0.02% 379

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alpine Global Management's SLDB Position: Q3 2024 in Review

Alpine Global Management sold out of Solid Biosciences (SLDB) in Q3 2024, closing a stake of 21,918 shares — an estimated $124K sold.

Alpine Global Management first reported a position in SLDB in Q2 2024 and held it in 1 quarter. The position peaked at $124K in Q2 2024. 92 funds tracked by Wall St. Rank hold SLDB as of Q3 2024.

  • Alpine Global Management reported no remaining Solid Biosciences position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 21,918 Solid Biosciences shares in Q3 2024, an estimated $124K.
  • Alpine Global Management first reported a position in Solid Biosciences in Q2 2024 and held it in 1 quarter.
  • Alpine Global Management's Solid Biosciences position peaked at $124K in Q2 2024.
  • 92 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.